Portland, OR, June 23, 2021 (GLOBE NEWSWIRE) – According to the report published by Allied Market Research, the Erythropoietin Drugs Market was set at $ 9.24 billion in 2020 and is expected to reach $ 14.41 billion by 2028, with a CAGR of 5.7% from 2021 to 2028.
Download a sample report from: https://www.alliedmarketresearch.com/request-sample/59
Rising prevalence of cancer, HIV, anemia and kidney disease, increasing level of awareness of benefits of EPO treatments, and commercialization of erythropoietin biosimilars are driving market growth Global Erythropoietin Medicines. However, longer treatment duration, unaffordability of treatments, and amount of unwanted side effects are hampering the growth of the market. On the contrary, the commercialization of the biosimilar darbepoetin alfa and the realization of economies of scale in developed regions are expected to open lucrative opportunities for market players in the future.
Covid-19 scenario:
- The Covid-19 outbreak has disrupted workflow in the healthcare sector as the rapid spread of the coronavirus has forced several industries to temporarily shut down.
- However, the pandemic has had a positive effect on the demand for medical services, including erythropoietin.
- Because erythropoietin is used to treat anemia and may be effective against Covid-19, which has boosted its demand. In addition, it has anti-ischemic, anti-apoptotic and regenerative effects in several tissues such as kidneys, lungs, nervous system, retina and pancreas. Thus, it can be used to treat critically ill patients.
The global erythropoietin drug market is segmented on the basis of product type, application, and region.
Based on product type, the epoetin-alfa segment held the lion’s share in 2020, accounting for over two-fifths of the market. However, the darbepoetin-alfa segment is estimated to register the highest CAGR of 7.0% during the forecast period.
Investigation of the short and long term impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/59
Based on applications, the kidney disorder segment dominated the market in 2020, contributing more than two-fifths of the market. Additionally, the segment is expected to post the highest CAGR of 6.5% during the forecast period.
The Global Erythropoietin Drugs Market is analyzed across several regions such as North America, Europe, Asia Pacific, and LAMEA. The North American market held the largest share in 2020, accounting for over a third of the market. However, the market across Asia-Pacific is expected to register the Highest CAGR 7.8% from 2021 to 2028.
Global Erythropoietin Drugs Market includes in-depth analysis of major market players such as Johnson & Johnson, Amgen Inc., Roche, Hospira Inc., Biocon, LG Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals, Ranbaxy Laboratories Ltd. and Celltrion, Inc.
Basic Avenue map | Access to the library | One year subscription |
Sign up for the Avenue subscription to access over 12,000 company profiles and over 2,000 niche market research reports at $ 699 per month per seat. For one year, the customer must purchase a minimum package of 2 places.
Avenue Library Subscription | Request 14-day free trial before purchasing: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We’ve also posted some syndicated market research in the same area that you might be interested in. Below is the title of the report for your reference, considering the impact of Covid-19 on this market, which will help you assess the aftermath of the pandemic on the short and long term growth trends of this market. market.
Similar reports:
Cell Culture Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
HIV Drugs Market Global Opportunity Analysis and Industry Forecast, 2019-2028
Renal Biomarkers Market Global Opportunity Analysis and Industry Forecast, 2019-2028
Dialysis Market Global Opportunity Analysis and Industry Forecast, 2019-2028
Covid-19 Diagnostics Market Global Opportunity Analysis and Industry Forecast, 2019-2028
Chemotherapy Induced Anemia Market Global Opportunity Analysis and Industry Forecast, 2019-2028
Biosimilars Market Global Opportunity Analysis and Industry Forecast, 2019-2028
About Us
Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global businesses as well as medium and small businesses with unmatched quality of “market research reports” and “business intelligence solutions”. AMR has a focused vision to provide business information and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.
We have professional relationships with various companies, which helps us extract market data which helps us generate accurate research data tables and confirm the highest accuracy in our market forecast. Allied market research CEO Pawan Kumar is essential in inspiring and encouraging everyone associated with the business to maintain high quality data and to help customers in every way possible to be successful. Each of the data presented in the reports we publish is extracted through primary interviews with senior officials of the main companies in the field concerned. Our secondary data sourcing methodology includes in-depth online and offline research and discussions with industry-savvy professionals and analysts.
